MAPK1, mitogen-activated protein kinase 1, 5594

N. diseases: 1059; N. variants: 13
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.380 AlteredExpression phenotype BEFREE A single ultra-low dose or repeated administration of morphine induced hyperalgesia in mice and caused a significant increase in the levels of p-ERK and p-JNK, but not p-p38, in the spinal dorsal horn. 31016764 2019
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.380 Biomarker phenotype BEFREE Our results showed that nicotine significantly reduced hyperalgesia in mice that received acute or repeated rapamycin injections, and reversed the effects of rapamycin on the phosphorylation of S6K, 4E-BP1, insulin receptor substrate-1 (IRS-1) at Ser636/639, AKT at Ser473, and ERK at Thr202/Tyr204. 31005665 2019
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.380 AlteredExpression phenotype BEFREE The expression of p-ERK was also depressed after intrathecal injection of AMG487 associated with a significant laxation of hyperalgesia, which demonstrated that the interaction of CXCL10/CXCR3 possibly took part in neuropathic pain by regulating p-ERK signaling in the SC. 30448292 2019
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.380 AlteredExpression phenotype BEFREE Down-regulation of HTR1As could induce VH in control rats with the increased expression of c-fos, p-ERK, and p-Akt in ACC, while up-regulation of HTR1As in the ACC could partly inhibit ACC sensitization and stress-induced visceral hyperalgesia. 31121088 2019
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.380 AlteredExpression phenotype BEFREE Epidural treatment with osthole could ameliorate NP-evoked hyperalgesia by suppressing the activation of ERK rather than decreasing the expression of ERK protein. 28486232 2017
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.380 Biomarker phenotype BEFREE Resveratrol alleviates inflammatory hyperalgesia by modulation of reactive oxygen species (ROS), antioxidant enzymes and ERK activation. 28647835 2017
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.380 PosttranslationalModification phenotype BEFREE This study was to investigate the role of p38 activation via ERK1/2 phosphorylation in neurons and microglia of the spinal trigeminal subnucleus caudalis (Vc) in the promotion of orofacial hyperalgesia induced by unilateral anterior crossbite (UAC) traumatic occlusion in adult rats. 27865869 2017
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.380 Biomarker phenotype BEFREE TRPA1 knockout or intrathecal administration of a TRPA1 antagonist (HC030031) attenuated methylglyoxal-evoked p-ERK, nociception, and hyperalgesia. 29270106 2017
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.380 Biomarker phenotype CTD_human Resveratrol suppresses glial activation and alleviates trigeminal neuralgia via activation of AMPK. 27093858 2016
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.380 Biomarker phenotype CTD_human Our data show that ERK activation plays a specific role in maintaining prolonged referred (secondary) hyperalgesia in visceral pain. 12941468 2003